Interview Questions for Keith Booher
1. Your talk emphasizes AI-driven workflows for identifying repurposed drugs. Can you share a specific case where your platform identified a treatment for a rare disease, and how it impacted patient outcomes?”
Interview Questions for Mike Snyder, PhD, Stanford
1. Can you describe a project or experience where you integrated data from wearables with multi-omics data? What were the main challenges you faced, and how did you address them?
We have several projects running right
Breaking: New Quantum Chip cuts Eons to 5min! – Hear from Nvidia’s CEO on AI in Healthcare + FDA Commissioner on AI concerns + more at PMWC Feb 5-7
The future of medicine is here—and it’s powered by AI. Imagine a world where AI personalizes your treatment, transforms how diseases are detected, and revolutionizes drug development. At PMWC 2025, February 5-7 in the Santa Clara Convention Center, we’ll bring this vision to life, showcasing how AI is reshaping healthcare and accelerating precision medicine.
Interview Questions for Michael E. Phelps, UCLA
Given the significant advancements in PET radiopharmaceuticals over the past decade, what do you see as the most promising areas for future development?
Interview Questions for Kari Stefansson, CEO of deCODE Genetics
Can you share details about a current project at deCODE that excites you the most, whether in multiomics or another area of research?
Interview Questions for Ida Sim
Your work with JupyterHealth is pioneering the secure collection and computation of health data from various sources. Could you share how JupyterHealth is currently being implemented in real-world healthcare
Interview Questions for Victor E. Velculescu
1. Integration of Liquid Biopsies:
“Given the rapid advancements in liquid biopsy technologies, including your development of DELFI, how do you envision their integration into routine clinical practice? Considering the current limitations, what
Interview Questions for Nicola Aceto
1. Your research has significantly advanced the understanding of circulating tumor cell (CTC) clusters in the bloodstream. Can you elaborate on the mechanisms that promote the formation of these clusters
Just Published: Groundbreaking AI Model for Cancer Diagnosis by Dr. Isaac Kohane – More at PMWC 2025
Dr. Isaac Kohane and his team have just published in Nature a groundbreaking research in cancer diagnosis using AI, introducing a new model that significantly outperforms current methods. This foundation model for clinical histopathology, trained on over 60,000 pathology slides and validated across 24 hospitals, sets a new standard for cancer diagnosis and prognosis.
Interview Questions for Julie Louise Gerberding
Q1: Public-private partnerships have been instrumental in recent advancements in medical research. Can you…
